SynthesisFrontiers in pharmacology2019

Head-to-Head Comparison of the Hypoglycemic Efficacy and Safety Between Dipeptidyl Peptidase-4 Inhibitors and α-Glucosidase Inhibitors in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials.

Zhaoliang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.